SUMMARY
INTRODUCTION
Semliki Forest virus (SFV) is an alphavirus which was first isolated from a pool of mosquitoes in Uganda in I942 (Smithburn & Haddow, I944) . It causes a fatal encephalitis in small mammals and has been widely used as a model for laboratory studies on pathogenicity. Strains of SFV differ widely in their virulence in experimental animals and the relative virulence of these strains in several host systems has been well characterized (Bradish et al. I97I, I972; Bradish & AUner, 1972) . However, these studies have failed to show which properties of the virus determine its virulence. One problem is that the different strains of SFV being used in comparative studies have been isolated from different pools of mosquitoes and have had different passage histories since isolation. These factors may have led to genetic drift. For this reason, we have adopted a different approach and have subjected a single strain of virus of known and high virulence to a chemical mutagen, in order to isolate mutants with altered virulence. Here we describe the isolation of four such mutants. Three of these were shown to differ from the wild-type (wt) in their ability to multiply in the mouse and produce lesions in nervous tissue.
oo22-I317/8o/oooo-4o59 $o2.00 © 1980 SGM Virus and host. The highly virulent strain LIo of SFV (Bradish et al. I97I) was obtained from Dr C. Bradish (MRE, Porton Down) . This was cloned three times by picking wellseparated plaques on BHK-2I cell monolayers after which a seed suspension was grown in neonatal mouse brain. This seed suspension was used to grow a large volume of stock suspension in neonatal mouse brain. Growth of BHK-21 cells and the method of plaque assay were as described by Atkins et al. (1974) . In order to minimize variation in the host, inbred Balb/c mice at ages of 1 to 3 days (neonatal) or 3o to 4o days (weanling) were used in all experiments.
Selection of mutants. Mutagenesis was carried out using N-nitro-N-methyl-N'-nitrosoguanidine as described by Atkins et al. (I974) . The mutated virus stock was diluted and plated on BHK-2I monolayers to give well separated plaques. Two hundred of these were picked, resuspended in I ml of BHK growth medium and frozen at -7o °C. As mice became available, these clones were thawed and 0"5 ml (1o 4 to IO 5 p.f.u.) injected i.p. into a single weanling mouse; the remaining o'5 ml was refrozen. If the animal survived for 14 days, the corresponding clone was rethawed, replated on BHK-eI cells, a single plaque again picked and the procedure repeated. If the mouse again survived infection, the virus was recloned, but suspended in 3 ml of growth medium and injected into four weanling mice. If all these survived infection, a stock of the mutant was grown in neonatal mouse brain, using the remaining cloned virus. This was harvested at 2 days p.i., diluted in Io-1 steps from Io 0 to Io -9 and then frozen in I ml and 4 ml amounts at -70 °C for use in pathogenicity studies. This whole procedure, but without mutagenesis and testing, was repeated for the wt virus to obtain a stock with an equivalent passage and cloning history.
Determination of virulence. Groups of six weanling mice were injected i.p. with 0"5 ml of Io ° to IO-9 dilutions of virus stock thawed from -7o °C. Litters of six neonatal mice were also injected intracerebrally (i.c.) with 0.02 ml of the same aliquots. Control mice injected with growth medium alone survived the procedure. Plaque assays of the dilutions on BHK2i cells were carried out with thawed aliquots of the dilutions, as cells became available. Four weeks after primary infection, the surviving weanling mice were challenged with Io 2 p.f.u, of wt virus given i.p.
Multiplication of the virus in weanling mice. Doses of IO 2 p.f.u, were injected i.p. into groups of Io weanling mice. Two animals were sacrificed at daily intervals up to 5 days p.i. and blood, brain and spinal cord extracted from individual mice. Blood was diluted to ro % (v/v) in phosphate-buffered saline, while brain and spinal cord were homogenized to a ~o % (w/v) suspension in BHK growth medium.
Pathology. Duplicate mice infected with wt SFV were killed 4, 5 and 6 days p.i.; those infected with mutants were killed 5 and 13 days p.i. The mice were anaesthetized with ether and perfused via the left ventricle with 3 % glutaraldehyde in phosphate buffer, pH 7"2, for ~ 5 rain. Brain and spinal cord were dissected out and transverse slices I to 2 mm thick were cut; one anterior to the third ventricle, one from the mid-brain at the level of the colliculi, one from the cerebellum and medulla at the level of the vestibular and dentate nuclei and six from the spinal cord. Larger slices of brain were subdivided by sagittal and horizontal cuts. The tissues were post-fixed in phosphate-buffered osmium tetroxide for 2 h, dehydrated with graded alcohols and embedded in Araldite. Thick (I to 2/zm) sections for light microscopy were stained with toluidine blue. Ultra-thin sections from selected areas were collected on uncoated grids, stained with uranyl acetate and lead citrate and examined at 60 kV in a Philips EM2oI electron microscope. The remainder of the brains and spinal cords was post-fixed in Io % formol-saline, embedded in paraffin wax, sectioned and stained with haematoxylin and eosin. 
RESULTS

Isolation of mutants
From a total of 2oo clones examined, four mutants with altered virulence were isolated. They are numbered, in order of isolation, M4, M9, MIo3 and MI36.
Determination of virulence
A classical LDso titration could be carried out for the wt virus in weanling mice and an LDs0 of I4 p.f.u, calculated by the Reed and Muench (I938) method. None of the mice surviving initial infection resisted challenge 4 weeks later.
For the four mutants, protection and death occurred for individual weanling mice at all doses between IO ~ and lO 7 p.f.u. This made the calculation of an LDs0 impossible. However, for neonatal mice, this did not occur and an LDs0 of I to IO p.f.u, could be calculated for each mutant and the wt. For the mutants, many surviving mice resisted challenge with wt virus 4 weeks p.i. Complete data for the mutant MI36 are shown in Table I ; a summary of the data is presented in Table 2 .
The mean time of death for the mutants and the wt in these titrations was significantly different ( Table 2 ). The symptoms of the disease were also different. Mice died of the wt infection abruptly with few previous symptoms; for the mutants, many mice showed progressive paralysis which was not observed for the wt. Since the mutants M4, MIo3 and MI36 allowed Ioo °/o survival in weanling mice injected with IO ~ p.f.u., we selected these for further study. In view of the apparently random death or protection of mice infected with the higher concentrations of mutant virus, we attempted to determine whether death of the mice at these concentrations was due to reversion of the mutants to wt during multiplication in the mouse. Accordingly, virus was isolated from the brains of single moribund mice injected with dilutions of the mutant stocks just above the Ioo ~'o survival dose. A stock of the putative revertant was grown in neonatal mouse brain, then IO ~, Io 4 and IO 6 p.f.u, injected i.p. into groups of six weanling mice. For the mutants M4 and MI36, all mice died within IO days, indicating that reversion had occurred. For MIo3, however, two mice died for IO 6 p.f.u, and Ioa p.f.u, but no mice died for ~o ~ p.f.u. ; all the surviving mice resisted challenge with wt virus 4 weeks p.i. Therefore reversion had occurred for MI36 and M4 but not for MIo3.
Multiplication in mice
The virus content of blood, brain and spinal cord of weanling mice injected i.p. with Io 3 p.f.u, of M4, M 9, M~o3 and wt virus was estimated at daily intervals for 5 days (Fig. I) . M 4 and MIo3 did not attain titres as high as the wt in the blood and were cleared by 3 and 2 days p.i., respectively, compared to 4 days for the wt. Maximum viraemia was achieved by MI36 2 days p.i. at a level only slightly lower than the maximum achieved by the wt virus at the same time. Both MI36 and the wt were cleared from the blood at 4 days p.i.
Virus could only be recovered from the brains of mice infected with wt and MI36 (Fig.  2) ; M I o3 and M4 could not be detected in the brain at any stage. Wt and M r36 were detected in the brain at 2 days p.i. The wt virus multiplied rapidly until titres approaching Io 8 p.f.u./g brain were present prior to death. MI36 reached titres of only ro ~ p.f.u./g brain and was cleared by 4 days p.i. No mutant virus could be recovered from the spinal cord at any stage; the wt was isolated from spinal cord 3 days p.i. until death, when titres approaching io 9 p.f.u./g were recovered. 
S F V virulence mutants
Pathology
Examination of the brain and spinal cord of mice 5 days p.i. with wt SFV revealed acute degenerative changes with pycnotic glial cells, leucocytic infiltration in the subarachnoid space and focal spongiform changes in the grey matter. These lesions increased greatly in severity between 5 days and 6 days p.i. when neuronal necrosis with neutrophilic infiltration of the neuropil was marked; they were always associated with large numbers of virus particles (Fig. 3) . No lesions were detected by light or electron microscopy in the brain and spinal cord of mice infected with M4 and M lO3. Occasional pycnotic glial cells were present in the brain and spinal cord of mice 5 days p.i. with MI36. At 13 days p.i. focal spongiform lesions were present in the grey matter of the brain and spinal cord accompanied by mononuclear cell infiltration in the perivascular spaces and marked Wallerian degeneration in the spinal cord. Ultrastructural examination demonstrated that the spongy degeneration seen with the light microscope was associated with the myelin sheath (Fig. 4) . No virus particles could be detected in these lesions.
D I S C U S S I O N
Previous studies on the effect of mutation on the pathogenicity of RNA viruses have used temperature-sensitive (ts) mutants (Stanners & Goldberg, 1975; Haspel et al. 1975; Rabinowitz et al. I976; Barrett & Atkins, 1979) . However, two studies (Rabinowitz et al. I977; Richmond, 1977) have found evidence for a mouse pathogenicity locus independent of the ts locus. In this study we have selected directly for mutants of SFV showing altered virulence in mice. Four mutants have been isolated and we have shown that these differ from the wt in their virulence for weanling, but not neonatal mice. The reason for the apparently random protection and death of mice injected with higher concentrations of mutant virus is not clear. For two mutants, but not a third, reversion of the mutation had occurred prior to death. However, it is not known whether this reversion had occurred before or after invasion of the brain, or whether revertants were present in the virus stock prior to injection of the mice. It is possible that invasion of the brain may occur in a proportion of mice following the rapid viraemia induced by high doses of virus and that reversion may occur subsequently. For three of the four mutants, however, it was possible to inject mice with io 2 p.f.u, of virus and obtain IOO % survival; this dose was lethal for the wt.
The multiplication of our mutants in weanling mice may be compared with the multiplication of the avirulent A774 strain of SFV studied by Pusztai et al. 0 9 7 0 . They found that the avirulent SFV caused a similar viraemia to the virulent strain. Both strains entered the brain, but the virulent strain multiplied to a higher titre than the avirulent strain. The latter strain, however, persisted in the brain for the duration of the experiment (96 h). Two of our mutants (M4 and MIo3) caused a transient viraemia and did not enter the brain. A third mutant (MI36) was able to cause a similar viraemia to the wt, but entered the brain only transiently and, unlike avirulent SFV, was eliminated. A further difference between our mutants and the wt is that the wt grew to high titre in the spinal cord, whereas the mutants could not be demonstrated in the spinal cord.
Lesions were produced in the brain following injection with wt and the mutant Mr36, but were not found in mice injected with M4 or MIo3-These data correlate well with those obtained for the multiplication of the mutants in mice. The lesions produced by the wt and MI36 differ in three respects. The wt virus produced more severe and generalized lesions than those caused by M ~ 36. Lesions occurred earlier in the wt infection although both viruses entered the brain at the same time (3 days p.i.). No virus particles were associated with the lesions caused by MI36 at ~3 days p.i., but the wt lesions were always associated with large numbers of virus particles. These results are similar to those obtained for avirulent strains of SFV. Suckling et al. (I978) reported that demyelination occurred in 25 % of mice injected with an avirulent strain of SFV, 14 to 28 days after a single i.p. injection. Chew-Lira et al.
(I978) reported that demyelination occurred 7 days after the last of three inoculations of avirulent SFV; no virus particles were associated with these lesions. Further studies on the pathogenesis of the lesions in the CNS of mice infected with MI36 are in progress.
Although the data obtained for our mutants are similar in some respects to those obtained for avirulent SFV, we believe that mutants will be more useful than avirulent strains in analysing the molecular basis of virulence for this virus. By comparing the multiplication and lesions produced by mutants with their molecular properties, it should be possible to analyse virulence at the molecular level in the absence of genetic drift.
